Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 339 participants.
Also called NCT05130268
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 339 participants
- Registry
-
NCT05130268
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05130268. Randomized; no masking; primary purpose treatment. Start 2021-10-29 (actual); primary completion 2024-01-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
- Acronym
- CHANGE-AFIB
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Dronedarone
- Lead sponsor
- American Heart Association
- Collaborator
- Duke Clinical Research Institute
- Collaborator
- Sanofi
Record details
- Record id
cardio:ct-nct05130268- Content hash
16cf8e5034568fddfbeb5da74a5bc3816530c28309dff14faa894c418f307f6c